Pulmonary Hypertension (PH) Completed Phase 3 Trials for Bosentan (DB00559)

Also known as: Pulmonary; Hypertension / Hypertension Pulmonary / Hypertension, Pulmonary / Pulmonary hypertensions / Pulmonary Hypertension / Other secondary pulmonary hypertension / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00319111Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Treatment
NCT00319020Bosentan in Children With Pulmonary Arterial Hypertension Extension StudyTreatment
NCT00319267Bosentan in Children With Pulmonary Arterial HypertensionTreatment
NCT00091715Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class IITreatment
NCT00820352Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary HypertensionTreatment